confessions
‘I know what it means to be searching for an explanation’

Camille MacMillin/STAT
In a provocative new essay for STAT, reporter Nick Florko gets personal. “When health secretary Robert F. Kennedy Jr. talks about the chronic disease epidemic ravaging America’s young, I am one of the people he is speaking about,” he writes, explaining that at 34, he is overweight and already suffering from high cholesterol, high blood pressure, and “ADHD so bad I often forget to brush my teeth in the morning.”
Nick writes that his own sometimes desperate search for answers has helped him understand what drives people to become skeptical of — and alienated from — the health system. “The more illuminating question isn’t whether people trust scientists,” he writes, “but rather what happens when scientific knowledge collides with emotions like fear, confusion, and frustration.” Read more on how Nick’s experience will inform his work as STAT’s first trust-in-science reporter.
And check out a new STATus Report on why trust in science matters, anyway.
vaccines
President Trump's newest vaccine 'demands'
A day after health secretary Robert F. Kennedy Jr. promised that parents concerned about vaccines had a “friend” in the White House, President Trump said he’ll be “demanding” that drug companies split up their combined vaccines.
“I think we are going to see a massive reduction in autism,” Trump said in the Oval Office Friday, repeating the debunked claim that vaccines cause autism.
Last month, Trump signed an executive order recommending fewer pediatric vaccines and calling for the combined measles, mumps, and rubella injection to be split into three shots. But on Friday, he went further, saying drug companies should only have “20%” of their doses in their shots, suggesting that children receive up to five injections of a single vaccine over time.
He also teased a forthcoming announcement by Centers for Medicare and Medicaid Services Administrator Dr. Mehmet Oz. — Chelsea Cirruzzo
Trials and tribulations
We need more information on medication in pregnancy. This fix could help
Nearly every drug trial is registered on ClinicalTrials.gov, a database of the Phase 2 to 4 tests underway. It’s a helpful tool for patients seeking a trial to join. But right now, there’s no easy way for pregnant and lactating people to find trials that will accept them.
That’s a problem — we need more data on how drugs interact (or don’t) with pregnancy. In a new First Opinion, three Brown professors argue that ClinicalTrials.gov should add a field to the eligibility criteria that flags whether a study enrolls pregnant or lactating women. “Improving ClinicalTrials.gov isn’t a panacea for the gaps in pregnancy data,” they write. “But it’s a straightforward and inexpensive improvement.” Read more.